Ir al contenido
· Rellenos dérmicos
SKU 11114

Revanesse Shape™+

En stock
Volumen
2 x 1,2 mL
Laboratorio
Prollenium Medical Technologies Inc.
Origen
Canadá
Indicación
Midface, jawline and chin structural support
El precio profesional y su historial son solo para cuentas verificadas
allpara suministra a profesionales autorizados. Inicie sesión o solicite una cuenta B2B para ver los precios en tiempo real, los tramos por volumen y el historial de precios.
Etiquetas

Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.

Principales ventajas de Revanesse Shape™+

  • Cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine for injection comfort
  • Indicated for medium to deep facial rhytides and for lipoatrophy
  • Placed in the middle part of the dermis layer
  • Implantation life averages 6 to 12 months
  • Supplied as two 1.2 mL pre-filled syringes with up to two sterilised 27G needles
  • BDDE cross-linked in phosphate-buffered saline
  • CE marked 0653 for the syringe, with CE 0123 needles
Información clave
Marca REVANESSE
Fabricante Prollenium Medical Technologies Inc.
País de origen Canada
Certificación CE marked 0653 for the syringe. The needles supplied are CE marked 0123.
Composición Cross-linked hyaluronic acid 25 mg/mL; lidocaine 0.3% w/w; in phosphate-buffered saline. Cross-linked with butanediol diglycidyl ether (BDDE).
Volumen / Tamaño 1.2 ml
Envase 2 pre-filled syringes x 1.2 mL, with up to two sterilised 27G needles
Tamaño de la aguja 27G, up to two supplied
Tipo de uso For professional use - injectable dermal filler with lidocaine, injected only by or under the direct supervision of qualified physicians trained in the technique for filling facial wrinkles
Profundidad de inyección Middle part of the dermis layer
Protocolo / Duración Implantation life averages 6 to 12 months, depending on the depth and location of injection

Indicaciones y uso profesional

Indicaciones principales

  • Medium to deep facial rhytides
  • Lipoatrophy

Uso profesional

For professional use. Revanesse Shape+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is placed in the middle part of the dermis layer. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand, prime the syringe until a small drop appears at the needle tip, and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, and must not contact quaternary ammonium salts such as benzalkonium chloride. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.

Zonas de tratamiento

  • Face

Perfil del paciente

For adult patients seeking correction of medium to deep facial rhytides or of lipoatrophy, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.

Cómo funciona Revanesse Shape™+ ​

Shape+ is a cross-linked hyaluronic acid gel that occupies volume in the dermis where it is placed, correcting medium to deep rhytides and the volume loss of lipoatrophy. Because it is placed in the middle part of the dermis rather than superficially, how long it lasts depends on the depth and location of the injection, which is why it lasts 6 to 12 months rather than a fixed period. The 0.3% lidocaine is present for injection comfort, which makes hypersensitivity to amide-type anaesthetics an outright contraindication.

Por qué comprar en Allpara

Allpara ofrece productos REVANESSE originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.

Preguntas frecuentes

How does Shape+ differ from Sculpt+?

They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.

/ Especificaciones

La ficha técnica

Categoría
Rellenos dérmicos
Marca
REVANESSE
Laboratorio
Prollenium Medical Technologies Inc.
SKU
11114
Formato
2 x 1,2 mL
Origen
Canadá
Indicación
Midface, jawline and chin structural support
Uso
Professional hyaluronic acid dermal filler
/ Detalles del producto

El expediente completo

Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.

Prollenium Medical Technologies Inc., país de origen Canadá.

Enviado a toda la UE desde nuestro almacén en la UE, con seguimiento y seguro, y envío en 24-72h. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote.

Conservar según las especificaciones del fabricante, protegido de la luz directa. La cadena de frío solo se utiliza cuando el producto lo requiere.

Condiciones de pago a 30 / 60 / 90 días* disponibles para cuentas verificadas previa aprobación de crédito. Se admite la facturación en EUR, CHF y GBP.

Las condiciones son orientativas y se confirman tras la revisión de la cuenta.

How does Shape+ differ from Sculpt+?

They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.

/ Respuestas rápidas

Todo lo que un comprador pregunta primero

How does Shape+ differ from Sculpt+?
They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.
What should a practitioner do if the skin blanches during injection?
Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.
/ FAQ

Preguntas frecuentes

They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.
Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.

Más productos de Prollenium Medical Technologies

Ver laboratorio

Alternativas para la clínica

Todos los productos

Revanesse Shape™+

En stock
Precios solo para cuentas verificadas
Inicie sesión o solicite una cuenta B2B para ver su precio.
Solicitar cuenta B2B

Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.

Principales ventajas de Revanesse Shape™+

  • Cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine for injection comfort
  • Indicated for medium to deep facial rhytides and for lipoatrophy
  • Placed in the middle part of the dermis layer
  • Implantation life averages 6 to 12 months
  • Supplied as two 1.2 mL pre-filled syringes with up to two sterilised 27G needles
  • BDDE cross-linked in phosphate-buffered saline
  • CE marked 0653 for the syringe, with CE 0123 needles
Información clave
Marca REVANESSE
Fabricante Prollenium Medical Technologies Inc.
País de origen Canada
Certificación CE marked 0653 for the syringe. The needles supplied are CE marked 0123.
Composición Cross-linked hyaluronic acid 25 mg/mL; lidocaine 0.3% w/w; in phosphate-buffered saline. Cross-linked with butanediol diglycidyl ether (BDDE).
Volumen / Tamaño 1.2 ml
Envase 2 pre-filled syringes x 1.2 mL, with up to two sterilised 27G needles
Tamaño de la aguja 27G, up to two supplied
Tipo de uso For professional use - injectable dermal filler with lidocaine, injected only by or under the direct supervision of qualified physicians trained in the technique for filling facial wrinkles
Profundidad de inyección Middle part of the dermis layer
Protocolo / Duración Implantation life averages 6 to 12 months, depending on the depth and location of injection

Indicaciones y uso profesional

Indicaciones principales

  • Medium to deep facial rhytides
  • Lipoatrophy

Uso profesional

For professional use. Revanesse Shape+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is placed in the middle part of the dermis layer. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand, prime the syringe until a small drop appears at the needle tip, and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, and must not contact quaternary ammonium salts such as benzalkonium chloride. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.

Zonas de tratamiento

  • Face

Perfil del paciente

For adult patients seeking correction of medium to deep facial rhytides or of lipoatrophy, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.

Cómo funciona Revanesse Shape™+ ​

Shape+ is a cross-linked hyaluronic acid gel that occupies volume in the dermis where it is placed, correcting medium to deep rhytides and the volume loss of lipoatrophy. Because it is placed in the middle part of the dermis rather than superficially, how long it lasts depends on the depth and location of the injection, which is why it lasts 6 to 12 months rather than a fixed period. The 0.3% lidocaine is present for injection comfort, which makes hypersensitivity to amide-type anaesthetics an outright contraindication.

Por qué comprar en Allpara

Allpara ofrece productos REVANESSE originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.

Preguntas frecuentes

How does Shape+ differ from Sculpt+?

They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.

Más productos de Prollenium Medical Technologies

Ver el laboratorio →

Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.

Prollenium Medical Technologies Inc., país de origen Canadá.

Enviado a toda la UE desde nuestro almacén en la UE, envío en 24-72h, con seguimiento y seguro. Cada unidad se envía con número de lote y fecha de caducidad, en depósito aduanero de la UE y con trazabilidad de lote. Conservar según las especificaciones del fabricante.

Pago a 30 / 60 / 90 días* para cuentas verificadas previa aprobación de crédito. Facturación en EUR, CHF y GBP.

How does Shape+ differ from Sculpt+?

They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.

* Producto de uso profesional. El envase puede variar según el lote o el mercado. Consulte las instrucciones de uso suministradas para las indicaciones completas y las contraindicaciones.